Color-flow duplex ultrasound scan versus computed tomographic scan in the surveillance of endovascular aneurysm repair  by Raman, Kathleen G et al.
From the Society for Clinical Vascular Surgery
Color-flow duplex ultrasound scan versus
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Muluk, MD, and Michel S. Makaroun, MD, Pittsburgh, Pa
Objective: The purpose of this study is to compare both computed tomographic scan (CT) and color flow duplex
ultrasound scanning (CDU) as surveillance modalities for clinically significant endoleaks and to evaluate concordance in
abdominal aortic aneurysm (AAA) diameter measurements in patients after endovascular aneurysm repair (EVAR) in a
busy hospital vascular laboratory.
Methods: We conducted a retrospective review of all patients who underwent endovascular repair of abdominal aortic
aneurysms between February 1996 and November 2002 and had same-day CT and CDU studies. Ninety-seven patients
enrolled in phase II clinical studies of Ancure devices had long-term follow-up with both modalities. The other patients
underwent simultaneous studies, usually only at the 1-month postoperative visit. Peripheral vascular studies were
performed by two certified vascular technicians; all CT scans were reviewed by one vascular surgeon. CT was used as the
standard against which the sensitivity, specificity, negative predictive value, and positive predictive value of CDU in
endoleak detection was determined. Statistics were performed by using the paired t test; a P value <.05 was considered
significant. Kappa statistic was used to assess the correlation between CDU and CT in identifying endoleaks. The
correlation between CT and CDU in AAA size measurements as well as in serial size measurements was also determined.
Results: Four hundred ninety-five same-day CT and CDU examinations were reviewed in 281 patients. Patients had an
average follow-up of 34.6 months (range, 1 to 72 months). Thirty-five leaks were identified among the patients studied
(12.4% overall). In comparison with CT, diagnosis of endoleak with ultrasound scanning was associated with a sensitivity
of 42.9%, specificity of 96.0%, positive predictive value of 53.9%, and negative predictive value of 93.9%. The correlation
between the two modalities was modest ( statistic 0.427). The minor axis transverse diameter as measured by ultrasound
and CT scans (4.81  1.1 cm on CT and 4.55  1.1 cm on ultrasound) correlated closely (r  .93, P < .001.) Seventy
percent of paired studies differed by<5 mm. Changes in aneurysm size throughout follow-up were.29 .71 cm on CT
scan .34  .57 cm on duplex ultrasound scan. The correlation coefficient was .65 (P < .001). There was no significant
difference in the change as measured by either modality on the paired t test.
Conclusions: Although CDU demonstrates a high degree of correlation with CT scan in determining aneurysm size change
over time, it has a low sensitivity and positive predictive value in endoleak detection. In the hospital vascular laboratory
at a large tertiary care center, CDU cannot effectively replace CT scan in surveillance after EVAR. (J Vasc Surg 2003;38:
645-51.)
Endovascular aneurysm repair (EVAR) has gained pop-
ularity since it was first reported by Parodi1 in 1991. Since
then, it has proven to be a useful alternative to open
aneurysm repair in selected patients.2,3 Although EVAR
offers immediate advantages over open aneurysm repair, it
carries with it the need for lifelong surveillance to monitor
aneurysm size and for potential complications, including
endoleak, change in aneurysm size, graft migration, struc-
tural graft failure, and limb outflow impairment caused by
limb stenosis or occlusion. Current modalities for EVAR
surveillance include computed tomography (CT) scan,
color-flow duplex ultrasound scanning (CDU), abdom-
inal radiograph, magnetic resonance imaging (MRI),
and angiography. The search continues for an optimal
means of surveillance for complications of EVAR, and
the use of each modality continues to evolve. Both CT
and CDU can detect endoleaks as well as size changes
over time. Although CT scan can, in addition, detect
graft migration, ultrasound scanning may be better
suited to detect limb flow abnormalities.
Recent reports have suggested that CDU is as effective
as, and in certain situations superior to, CT in endoleak
detection after EVAR. These enthusiastic reports, however,
were not easy to duplicate in most other laboratories.4 The
purpose of this study was to compare both CT scan and
CDU performed in the vascular laboratory at a large tertiary
care center, as modalities of surveillance for endoleak de-
tection and change in aneurysm size over time after EVAR.
METHODS
We evaluated 281 patients who had undergone endo-
vascular repair of abdominal aortic aneurysm (AAA) with
the Ancure (247) (Guidant, Menlo Park, Calif) or AneuRX
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(34) (Medtronic, Santa Rosa, Calif) endograft at the Uni-
versity of Pittsburgh Medical Center from February 1996
to November 2002. Of these patients, 97 had been en-
rolled in a phase II Food and Drug Administration proto-
col. Follow-up of these patients included same-day ultra-
sound, CT, and abdominal radiograph in the first
postoperative month, then at 6 months, 12 months, and
yearly thereafter. Patients who underwent routine endovas-
cular aneurysm repair with commercial endografts under-
went same-day studies only 30 days postoperatively. The
residual follow-up was with CT scans only at the same
intervals as the protocol patients. CDU was substituted if
the patient had a contrast allergy or elevated creatinine.
This study protocol was reviewed and approved by the
Institutional Review Board of the University of Pittsburgh.
Duplex ultrasound. All duplex scans were performed
by a registered vascular technologist in a fully accredited
hospital vascular laboratory. An Acuson 128 XP ultrasound
machine (Mountain View, Calif) and 3- to 5-MHz trans-
ducers were used. Patient encounters were scheduled for 45
minutes, with 20 minutes devoted to actual scanning. A
protocol standardized for the vascular laboratory was used
for assessing the abdominal aorta, aortic bifurcation, and
iliac vessels. This protocol consisted of obtaining longitu-
dinal and transverse views of the proximal, mid, and distal
aorta and iliac arteries. Peak systolic velocities were ob-
tained in the graft and then compared with velocities in the
iliac vessels to assess for the presence of limb flow anomalies
including stenosis or occlusion. Color flow duplex scanning
and Doppler interrogation of the sac was used to rule out
the presence of perigraft flow. Endoleak detection was
based on direct visualization and spectral confirmation of
perigraft flow into an aneurysm sac. All CDUs were re-
viewed by a vascular surgeon. The ultrasound scanning
technologist and the surgeon reviewing the tapes were both
unaware of the results of CT scan during any portion of the
ultrasound scan examination or review. A technically ade-
quate study was defined as a study that allowed visualization
of the aneurysm sac and flow within the graft. All patients
were asked to fast before they reported for the scan.
CT scan. Helical CT was performed with a Lightspeed
QXi multi-detector-row CT scanner (General Electric
Medical Systems, Milwaukee, Wis).5 Precontrast studies
were obtained routinely. Contrast CT scans were per-
formed after a Smart Prep series. One hundred twenty-five
milliliters of nonionic iodinated contrast medium were
injected at a speed of 4 mL/second. CT scans were ob-
tained with a 2.5-mm slice thickness throughout the scan,
which started 1 cm above the celiac axis and ended at the
femoral bifurcation. All CT scans were reviewed by a single
vascular surgeon (M.S.M). Size measurements were all
performed by using an electronic caliper tool. No delayed
imaging was performed for the detection of questionable
endoleaks in the cohort included in this report. A techni-
cally satisfactory study included all required portions of the
examination, as noted previously.
Statistics. CT and ultrasound scanning studies were
compared for the determination of aneurysm size, diagno-
sis of endoleak, and graft patency. Using CT as the stan-
dard, the sensitivity, specificity, positive predictive value,
and negative predictive value of CDU was determined in
endoleak detection. The patients who were enrolled in
phase II studies had longitudinal follow-up. Aneurysm
diameter (minor axis) was compared on serial examinations
to assess for growth or shrinkage. For each paired CT and
CDU examination studied, the mean pair difference was
calculated and the hypothesis that this value was not differ-
ent from zero was tested with the paired t test. The limits of
agreement, representing the range within which 95% of the
differences would be expected to occur, were calculated as
the mean difference 1.96 times the SD of the differences,
according to the method of Bland and Altman.6 AAA size
change was determined by subtracting minor axis measure-
ments by CT and CDU from the previous measurement,
which was separated by either 6 or 12 months. Statistical
analysis included calculation of the Pearson correlation
coefficient and the paired t test. Results are expressed as
mean SD, and a P value less than .05 was considered
significant. The  statistic was used to determine how well
CT and CDU correlated in endoleak detection.
RESULTS
The charts, CT scans, and peripheral vascular studies of
281 patients (246 males, 35 females) with a mean age of 73
 7 (range, 47 to 90 years) were reviewed. A total of 494
postoperative same-day CT scans and CDU scans were
obtained (3.8 1.4 per patient; range, 1 to 7) over a 1- to
72-month follow-up period (mean 34.6  2 months). All
CT scans and CDU were technically satisfactory for deter-
mination of aneurysm size and presence of endoleak.
Endoleak. Thirty-five leaks were identified (12.4%
overall). Twelve type I leaks were identified (Fig 1); 3
patients were treated with a proximal cuff extender, 4
underwent iliac stent placement, 4 leaks resolved with
expectant management, and 1 patient refused follow-up.
Twenty-three type II endoleaks were identified (Fig 2); 15
patients underwent coil embolization of either an IMA or
lumbar artery, and 8 leaks resolved with expectant manage-
ment. A comparison of endoleak detection by means of
same-day CT and CDU is presented in the Table. Both
modalities were concordant in 448 (91%) of the observa-
tions. In 46 (9%) of the paired studies, the two modalities
indicated opposite findings. CDU did not detect endoleaks
clearly noted on CT in 28 cases (false negatives), and it
suggested a positive finding in 18 studies not confirmed by
the CT scan (false positives). One of these patients had an
endoleak on CDU in the early postoperative examination
that resolved by 6 months. He went on to develop a type 2
endoleak from a lumbar artery 4 years later, which was then
detected by CT, but not by CDU. There were no other
instances of CDU initially identifying an endoleak not
corroborated by CT scan. Using CT as the gold standard,
diagnosis of endoleak with CDU was associated with a
sensitivity of 42.9%, specificity of 96.0%, positive predictive
value of 53.9%, and negative predictive value of 93.9%. The
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measure of agreement between the two modalities was
modest ( statistic .427).
In order to determine the clinical significance of the
false negatives on CDU, we further analyzed the outcomes
of these patients. Eleven of the 28 false-negative examina-
tions were identified as having type 1 endoleak by CT scan;
seven of these patients required interventions, whether
placement of proximal cuff extenders or iliac stents. Seven-
teen of the 28 false-negative examinations were identified
as having type 2 endoleak by CT scan; eight of these
patients required coil embolization of the sac as well as an
IMA or lumbar artery. No patients with false-positive
CDUs were noted to experience enlargements over time or
require any intervention. One patient with an early en-
doleak noted only on CDU but not on CT actually devel-
oped a type II endoleak only detected on CT scan 4 years
later, after all intervening tests were negative. The aneu-
rysm of this patient is collapsed, and no intervention has yet
been undertaken.
Aneurysm size. The minor axis diameter as measured
by CT scan and CDU (4.81  1.1 cm on CT and 4.55 
1.1 cm on CDU) correlated closely (r .93, P .001 [.89
to .97]) (Fig 3). However, there was a significant difference
between the measurement of minor axis between CT and
CDU by paired t test (P  .001). The Bland Altman plot
(Fig 4) demonstrated consistent variability at all aneurysm
diameters, with the CT measurement usually exceeding the
CDU measurement. AAA size change was analyzed (using
serial studies). Overall, 148 diameter measurements were
calculated for each CT and CDU. Changes in aneurysm
size were .29  .71 cm on CT scan, .34  .57 cm on
CDU (Fig 5). The correlation coefficient was .65 (P 
.001). There was no significant difference in the change in
aneurysm diameter over time as measured by either modal-
ity on paired t test.
Fig 1. Example of proximal type I endoleak as depicted with A. Color duplex ultrasound scanning (yellow arrow). (B)
CT scan (yellow arrow).
Fig 2. Example of type II endoleak originating from lumbar artery as depicted with A. Color duplex ultrasound
scanning (yellow arrow). (B) CT scan (yellow arrow).
Correlation between CT and CDU for presence of
endoleak postoperatively.
CDU
CT scan
No endoleak Endoleak
No endoleak 427 28
Endoleak 18 21
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DISCUSSION
After EVAR, the need for lifelong surveillance drives
the search for an optimal means of monitoring aneurysm
size changes, endoleak, structural failures, and limb abnor-
malities. A successful outcome may be defined as complete
aneurysm exclusion without the presence of an endoleak.
Although several series have placed the incidence of post-
operative endoleak between 10% and 50%,7-9 the clinical
Fig 3. Correlation between postoperative CT and CDU (n  494 pairs) for measurement of transverse aneurysm
diameter (minor axis). Pearson correlation coefficient used to determine coefficient (r,.93; P .001). In 70% of the
scans, diameter measurements differed by less than 5 mm.
Fig 4. Bland Altman plot of postoperative CT and CDU measurement of aneurysm size. The mean difference between
CT and CDU measurements plotted against mean aneurysm diameter. The limits of agreement (.93 to .93) represent
the range within which 95% of the differences would be expected to occur, and were calculated as the mean difference
 1.96 times the SD of the differences.
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significance of these early endoleaks is not clear. Over 50%
of initially identified endoleaks seal spontaneously, and the
subsequent clinical course of patients with sealed endoleaks
does not differ from patients who never had one document-
ed.10,11 Endoleak onset is highly variable and unpredict-
able. The problem is exemplified by a report of a patient
with a sealed endoleak that later reopened, leading to
nonfatal rupture.10 A reliable and reproducible diagnostic
tool is thus required for accurate follow-up of endoleaks in
EVAR patients. The ideal tool would also be very accurate
in detecting other parameters of failure or success. AAA size
reduction over time has been used as a surrogate marker for
successful exclusion, while enlargement has suggested ei-
ther an endoleak or endotension.12 Both CT and CDU can
offer diagnostic help for endoleak detection and size reduc-
tion.
Although abdominal radiographs are useful to interro-
gate graft integrity and assess for evidence of device fatigue,
CT scans have been used as the gold standard with which to
assess aneurysm diameter and the presence of en-
doleaks.13-16 The benefits of CT as an imaging modality
over CDU include the fact that it is highly reproducible,
less influenced by body habitus, and offers faster image
acquisition. However, it is important to note that CT scans
are not without their limitations, including repeated radia-
tion exposure, potential contrast-related complications in-
cluding allergy and worsening renal insufficiency, and high
cost of serial examination. Further, Lederle17 reported a
significant degree of interobserver variability in AAA mea-
surement (2 mm in 65%, but may differ by 5 mm in
17%).
CDU is a potentially attractive alternative imaging
technique. It is less invasive, less expensive, and does not
require repeated exposure to radiation or to contrast
agents. However, CDU is more operator-dependent and is
significantly affected by the patients’ body habitus and
fasting status. In addition, ultrasound scanning measure-
ments have been noted to underestimate the true size of the
AAA when compared with CT, and they have at least as
much inter-observer variability.17
Our results in this study show a size difference in AAA
measurement by CT and CDU. These differences are small,
and they are unlikely to be clinically significant in most
cases, given that 70% of paired studies differed by 5 mm.
There was a good correlation between CDU and CT in
determining aneurysm size changes over time. This verifies
that the detection of size change can be performed equally
well by either modality. However, with a low sensitivity and
positive predictive value, CDU at our site was not an
effective means of endoleak detection. The correlation
between CT and CDU was only modest. We obviously
cannot exclude the possibility that endoleaks identified by
CDU and interpreted as false positives are, in fact, true
findings missed by the CT scan, especially in the absence of
delayed CT imaging. To date, we have identified only one
patient with a positive early CDU associated with a negative
Fig 5. Comparison between CT and CDU for serial examinations of AAA size after EVAR (n 148 pairs). Each point
on plot represents the difference between two consecutive measures separated by 6 to 12 months. Pearson correlation
coefficient used to determine coefficient (r, .65; P  .001).
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CT who went on to develop an endoleak at 4 years that was
then detected by CT scan only. Numerous technical factors
influence the diagnostic value of a CT scan. Scan timing
after the contract injection is crucial to detecting the arterial
phase of the contrast and is helped by a Smart Prep series.
However, endoleaks may fill slowly and cannot be identi-
fied on the early scan. Delayed images may be necessary
when low-flow endoleaks are suspected. Our failure to use
this technical refinement may have falsely elevated the
detected CDU false positives, although we did not recog-
nize late endoleaks on serial follow-up not detected by
initial CT scans. Fine reconstructions on both the con-
trasted and noncontrasted images are essential to rule out
artifacts, including plate-like calcifications in the AAA from
being mistaken for endoleaks.
Similarly, technical factors can be very important in the
diagnostic value of a CDU. Numerous recent reports from
selected centers have documented excellent results using
CDU in EVAR surveillance. Some even suggest a superior-
ity of CDU over CT scan, claiming a higher sensitivity in
detecting endoleaks proven by later clinical follow-up. Sato
et al4 reported excellent sensitivity (97%) and negative
predictive value (98%) in the detection of endoleak. How-
ever, in reviewing 117 tapes of CDU examinations from 18
different centers, the same authors found only 19% of these
studies to be technically adequate. Their findings suggest
that serious differences exist between CDU studies per-
formed at different locations due to technical issues limiting
the general recommendation that CDU be the preferred
method of follow-up. The factors involved in this variability
are clear from these reports: Study time is quoted to average
90 minutes with high-end machines not uniformly available
in many vascular laboratories. Technologist experience as
well as deliberate extended scan times may be necessary to
identify small or slow endoleaks. Modern scanners have
significantly improved B mode imaging and Doppler func-
tions that can identify not only the presence of endoleaks,
but also the direction of flow in the endoleak.
Although our technologists are very experienced, our
use of relatively older equipment and short scan times may
have been the main culprit in the inadequate correlation
between CDU and CT in the detection of endoleaks. Our
Acuson 128 XP scanners were last upgraded in 1999, and
although this study covered the period from 1996 to 2002,
the equipment has since been supplanted by scanners with
significant technical improvements. Nevertheless, we be-
lieve that most large hospital laboratories have not uni-
formly upgraded to newer equipment. Therefore, it is
essential that clinical decisions based on CDU be under-
taken only after a review of local results indicates equivalent
or superior results with this modality when compared to
CT scanning. Our review of a large number of same-day
paired studies indicated that the excellent results reported
recently by others could not be duplicated in a hospital
vascular laboratory that can dedicate only 20 minutes of
actual scan time to such an examination. Congested waiting
lists for vascular studies and an inability to attract enough
trained technologists have limited the ability of our hospital
laboratory to devote longer time periods to each study. The
lack of additional diagnostic utility of CDU over CT scan-
ning under these conditions has led us to abandon CDU as
a routine test for EVAR surveillance.
Heilberger et al18 showed that the addition of a con-
trast agent (Levovist) during CDU examination greatly
increased the sensitivity of CDU in endoleak detection.
McWilliams et al19 also showed that the addition of Levo-
vist improved the sensitivity of CDU, but that there was an
increased number of false positives; they attributed the
overestimate of endoleak to either the blooming of color
arising from adjacent vessels or to aneurysm wall inflamma-
tion. Most recently, Bendick et al20 have reported on the
use of a different ultrasound scanning contrast agent (Op-
tison, Mallinckrodt, St Louis, Mo) combined with digitally
encoded tissue harmonic imaging, which suppressed the
artifacts associated with CDU and found no false positives.
These adjuncts require modern equipment and can cer-
tainly improve the diagnostic utility of CDU if they can be
applied effectively, thereby reducing the reliance on CT
scanning. In addition to the equipment needed, the intra-
venous delivery of most of these agents and the typical
hospital laboratory staffing with technologists who are nei-
ther skilled nor permitted to administer these agents have
limited their widespread use. We had no access to this
enhancing technology in our hospital’s vascular laboratory.
Our results are not unique. Pages et al21 reported a 42%
sensitivity of CDU in endoleak detection but a fair reliabil-
ity for surveillance of aneurysm diameter. Additionally,
studies describing the use of adjunctive contrast agents in
performing CDU have reported sensitivities of 12% for
unenhanced ultrasound scanning and 50% for enhanced
power Doppler,19 concluding that even with the use of
contrast agents, CT imaging remains the surveillance mo-
dality of choice.
Other measures obtained by various techniques may in
time prove to increase the utility of these techniques in
EVAR surveillance. Volume measurements obtained prin-
cipally from 3-D reconstructions of CT data have been
recently promoted as a more sensitive measure of successful
exclusion and the absence or presence of endoleaks.22 Such
follow-up of volume data may offer early warning of inad-
equate exclusion of the AAA. On the other hand, Arko et
al23 recently reported that intrasac flow velocities may help
in predicting whether type II endoleaks will seal spontane-
ously. Such technique refinements may in the future weigh
in favor of adopting one technique over the other in routine
follow-up.
The need for lifelong surveillance after EVAR mandates
reliable diagnostic tools to detect potential complications.
Our data suggest that the favorable results of CDU at
selected centers cannot be reproduced everywhere. Cau-
tion should be exercised, and the individual reliability of
CDU should be tested at the local facility before it is
adopted as a suitable substitute for CT scanning. We con-
clude that ultrasound scanning performed in a hospital
vascular laboratory such as ours cannot effectively replace a
CT scan in surveillance after EVAR.
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